Syneron Medical (ELOS) Reports Q1 Adj-Loss of $0.23

May 14, 2009 7:49 AM EDT

Syneron Medical Ltd. (Nasdaq: ELOS) reports Q1 loss of $0.23, ex-items, versus the analyst estimate of ($0.16). Revenue for the quarter was $11.9 million, versus the consensus of $14.42 million.


Related Categories

Earnings

Stocks Mentioned

ELOS 10.12

+0.00 +0.00%
Volume: 129,737
Track ELOS


Add Your Comment